TELA Revenue Flow
Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
- 2026-06-30: Revenue $19.29M; Research and development $2.72M; Operating expenses $23.23M; Income tax $60.00K.
- 2026-03-31: Revenue $19.06M; Research and development $2.34M; Operating expenses $23.05M; Income tax $60.00K.
- 2025-12-31: Revenue $20.87M*; Research and development $2.13M*; Operating expenses $20.40M*; Income tax $145.00K*.
- 2025-09-30: Revenue $20.69M; Research and development $2.35M; Operating expenses $21.52M; Income tax (m).
Major Customers
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Geography
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Segment
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown
Revenue and expense 3 month
| Period end | Revenue | Research and development | Operating expenses | Income tax | Net income |
|---|---|---|---|---|---|
| 2026-06-30 | $19.29M | $2.72M | $23.23M | $60.00K | -$11.26M |
| 2026-03-31 | $19.06M | $2.34M | $23.05M | $60.00K | -$12.27M |
| 2025-12-31 | $20.87M* | $2.13M* | $20.40M* | $145.00K* | -$9.01M* |
| 2025-09-30 | $20.69M | $2.35M | $21.52M | (m) | -$8.60M |
| 2025-06-30 | $20.20M | $2.20M | $23.19M | $33.00K | -$9.92M |
| 2025-03-31 | $18.52M | $2.54M | $22.98M | $52.00K | -$11.26M |
| 2024-09-30 | $18.96M | $2.07M | $22.22M | (m) | -$10.37M |
| 2024-06-30 | $16.09M | $2.32M | $22.64M | (m) | -$12.60M |
| 2024-03-31 | $16.60M | $2.39M | $23.74M | (m) | -$5.66M |
| 2023-09-30 | $15.05M | $2.37M | $20.57M | (m) | -$10.96M |
| 2023-06-30 | $14.49M | $2.51M | $20.56M | (m) | -$10.79M |
| 2023-03-31 | $11.91M | $2.05M | $19.15M | (m) | -$12.03M |
| 2022-09-30 | $11.16M | $2.10M | $16.81M | (m) | -$10.71M |
| 2022-06-30 | $10.41M | $2.10M | $16.79M | (m) | -$12.74M |
| 2022-03-31 | $8.23M | $2.01M | $14.84M | (m) | -$10.86M |
| 2021-09-30 | $7.65M | $1.41M | $11.82M | (m) | -$8.27M |
| 2021-06-30 | $7.56M | $1.93M | $12.40M | (m) | -$8.26M |
| 2021-03-31 | $5.88M | $1.68M | $10.73M | (m) | -$8.14M |
| 2020-09-30 | $5.31M | $1.20M | $10.15M | (m) | -$7.70M |
| 2020-06-30 | $3.51M | $979.00K | $7.25M | (m) | -$6.08M |
| 2020-03-31 | $3.73M | $912.00K | $8.70M | (m) | -$7.22M |
| 2019-09-30 | $3.97M | $516.00K | $6.46M | (m) | -$4.67M |
| 2019-06-30 | $3.30M | $1.05M | $6.21M | (m) | -$5.26M |
| 2019-03-31 | $3.31M | $1.66M | $6.98M | (m) | -$5.97M |
| 2018-09-30 | $2.21M | $1.04M | $3.89M | (m) | -$2.81M |
Revenue and expense 6 month
| Period end | Revenue | Research and development | Operating expenses | Income tax | Net income |
|---|---|---|---|---|---|
| 2026-06-30 | $38.35M | $5.07M | $46.27M | $120.00K | -$23.54M |
| 2025-06-30 | $38.72M | $4.74M | $46.17M | $85.00K | -$21.19M |
| 2024-06-30 | $32.69M | $4.72M | $46.38M | (m) | -$18.26M |
| 2023-06-30 | $26.40M | $4.57M | $39.72M | (m) | -$22.82M |
| 2022-06-30 | $18.64M | $4.11M | $31.63M | (m) | -$23.60M |
| 2021-06-30 | $13.44M | $3.61M | $23.13M | (m) | -$16.39M |
| 2020-06-30 | $7.23M | $1.89M | $15.95M | (m) | -$13.30M |
| 2019-06-30 | $6.61M | $2.71M | $13.19M | (m) | -$11.23M |
Revenue and expense 9 month
| Period end | Revenue | Research and development | Operating expenses | Income tax | Net income |
|---|---|---|---|---|---|
| 2025-09-30 | $59.41M | $7.09M | $67.69M | $85.00K | -$29.79M |
| 2024-09-30 | $51.65M | $6.78M | $68.61M | (m) | -$28.63M |
| 2023-09-30 | $41.45M | $6.93M | $60.28M | (m) | -$33.77M |
| 2022-09-30 | $29.80M | $6.21M | $48.44M | (m) | -$34.32M |
| 2021-09-30 | $21.09M | $5.02M | $34.95M | (m) | -$24.66M |
| 2020-09-30 | $12.55M | $3.09M | $26.10M | (m) | -$21.00M |
| 2019-09-30 | $10.58M | $3.23M | $19.64M | (m) | -$15.89M |
| 2018-09-30 | $5.85M | $3.36M | $14.20M | (m) | -$13.70M |
Revenue and expense 12 month
| Period end | Revenue | Research and development | Operating expenses | Income tax | Net income |
|---|---|---|---|---|---|
| 2025-12-31 | $80.28M | $9.22M | $88.10M | $230.00K | -$38.80M |
| 2024-12-31 | $69.30M | $8.81M | $88.18M | -$144.00K | -$37.80M |
| 2023-12-31 | $58.45M | $9.62M | $84.19M | (m) | -$46.70M |
| 2022-12-31 | $41.42M | $8.94M | $66.05M | (m) | -$44.30M |
| 2021-12-31 | $29.46M | $6.74M | $48.26M | (m) | -$33.28M |
| 2020-12-31 | $18.21M | $4.25M | $36.51M | (m) | -$28.79M |
| 2019-12-31 | $15.45M | $4.15M | $28.43M | (m) | -$22.43M |
| 2018-12-31 | $8.27M | $4.34M | $20.72M | (m) | -$21.09M |
| 2017-12-31 | $4.25M | $5.79M | $19.46M | (m) | -$21.33M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |